Aeterna Zentaris, China National Pharmaceutical Group deal

Sinopharm’s Sinopharm A-Think subsidiary received exclusive rights from Aeterna Zentaris to develop and commercialize Zoptarelin doxorubicin acetate to treat endometrial cancer in China, including Hon...